RxDoctor Payments Data

William Dupps, MD

Ophthalmology · Cleveland, OHNPI 1760598296

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $38,628 of the $43,995 with a category attached, or 87.8%. 6 manufacturers reported payments, led by Alcon Research LLC at 39.3% of the total. 2025 is the largest year on record at $13,168, 2.4 times the $5,387 reported in 2019. Among ophthalmology clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$43,995in general payments, 2019–2025

Across 39 payments — averaging $1128.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Alcon Research LLC$17K
  • Glaukos Corporation$16K
  • Alcon$8K
  • Carl Zeiss Meditec, Inc.$2K
  • Johnson & Johnson Surgical Vision, Inc.$550
  • Carl Zeiss Meditec USA, Inc.$36
$176,106in research payments, 2019–2025

Across 192 payments — averaging $917.22 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Alcon Research LLC$176K

What the payments were for

  • Consulting fees$38,62888%
  • Speaking & faculty fees$2,4506%
  • Travel & lodging$1,9784%
  • Food & beverage$9022%
  • Gifts$360%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$43,995 in reported general payments places this provider in the 95th percentile of 640 ophthalmology providers in Ohio.

See all ophthalmology providers in Ohio

Medicare billing

Part B allowed, 2024
$20,025
Medicare patients
68
Services billed
166

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Prednisolone Acetate62$2,283

Paid to pharmacies, not to this prescriber.

Other ophthalmology in Cleveland

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →